Notice: This company has been marked as potentially delisted and may not be actively trading. Cesca Therapeutics (KOOL) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsDividendTrends KOOL vs. THMO, KEQU, ZURA, ECOR, MIST, ACHV, CRDL, TELA, MGX, and MLSSShould you be buying Cesca Therapeutics stock or one of its competitors? The main competitors of Cesca Therapeutics include ThermoGenesis (THMO), Kewaunee Scientific (KEQU), Zura Bio (ZURA), electroCore (ECOR), Milestone Pharmaceuticals (MIST), Achieve Life Sciences (ACHV), Cardiol Therapeutics (CRDL), TELA Bio (TELA), Metagenomi (MGX), and Milestone Scientific (MLSS). Cesca Therapeutics vs. ThermoGenesis Kewaunee Scientific Zura Bio electroCore Milestone Pharmaceuticals Achieve Life Sciences Cardiol Therapeutics TELA Bio Metagenomi Milestone Scientific Cesca Therapeutics (NASDAQ:KOOL) and ThermoGenesis (NASDAQ:THMO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, community ranking, media sentiment, institutional ownership, earnings, profitability, valuation and risk. Which has more risk & volatility, KOOL or THMO? Cesca Therapeutics has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, ThermoGenesis has a beta of 2.45, indicating that its share price is 145% more volatile than the S&P 500. Which has stronger valuation and earnings, KOOL or THMO? ThermoGenesis has lower revenue, but higher earnings than Cesca Therapeutics. Cesca Therapeutics is trading at a lower price-to-earnings ratio than ThermoGenesis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCesca Therapeutics$9.67M2.79-$39.72M-$3.60-3.10ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A Does the media refer more to KOOL or THMO? In the previous week, Cesca Therapeutics' average media sentiment score of 0.00 equaled ThermoGenesis'average media sentiment score. Company Overall Sentiment Cesca Therapeutics Neutral ThermoGenesis Neutral Does the MarketBeat Community believe in KOOL or THMO? Cesca Therapeutics received 241 more outperform votes than ThermoGenesis when rated by MarketBeat users. Likewise, 70.45% of users gave Cesca Therapeutics an outperform vote while only 60.47% of users gave ThermoGenesis an outperform vote. CompanyUnderperformOutperformCesca TherapeuticsOutperform Votes26770.45% Underperform Votes11229.55% ThermoGenesisOutperform Votes2660.47% Underperform Votes1739.53% Do institutionals and insiders hold more shares of KOOL or THMO? 3.1% of Cesca Therapeutics shares are held by institutional investors. Comparatively, 5.8% of ThermoGenesis shares are held by institutional investors. 68.9% of Cesca Therapeutics shares are held by insiders. Comparatively, 78.0% of ThermoGenesis shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is KOOL or THMO more profitable? ThermoGenesis has a net margin of 0.00% compared to Cesca Therapeutics' net margin of -98.84%. ThermoGenesis' return on equity of 0.00% beat Cesca Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Cesca Therapeutics-98.84% -77.30% -37.75% ThermoGenesis N/A N/A N/A SummaryThermoGenesis beats Cesca Therapeutics on 8 of the 12 factors compared between the two stocks. Get Cesca Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for KOOL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOOL vs. The Competition Export to ExcelMetricCesca TherapeuticsLaboratory Apparatus & Furniture IndustryMedical SectorNASDAQ ExchangeMarket Cap$26.95M$179.46M$5.56B$9.10BDividend Yield0.50%N/A5.32%3.99%P/E Ratio-3.1010.1990.3018.28Price / Sales2.790.911,250.4080.65Price / CashN/A49.0645.9637.70Price / Book3.594.735.124.70Net Income-$39.72M$18.75M$111.33M$224.47M Cesca Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KOOLCesca TherapeuticsN/A$11.16-0.6%N/A+2,195.9%$26.95M$9.67M-3.1053THMOThermoGenesisN/A$0.00flatN/AN/A$6,000.00$9.44M0.0040KEQUKewaunee Scientific1.4003 of 5 stars$58.45-4.1%N/A+128.5%$167.87M$199.64M9.261,006Short Interest ↓ZURAZura Bio3.4046 of 5 stars$1.66-3.5%$15.80+851.8%-34.0%$108.38MN/A0.003ECORelectroCore2.9726 of 5 stars$16.49-3.1%$25.00+51.6%+120.9%$108.01M$16.03M-9.0150Short Interest ↓News CoveragePositive NewsMISTMilestone Pharmaceuticals2.4287 of 5 stars$2.02-1.5%$13.00+543.6%+23.1%$107.73M$1M-2.4930Short Interest ↑Analyst RevisionNews CoverageACHVAchieve Life Sciences1.8739 of 5 stars$3.12+4.5%$14.80+375.1%-33.7%$107.13MN/A-2.7620Short Interest ↑News CoverageCRDLCardiol Therapeutics2.006 of 5 stars$1.29-11.6%$8.75+578.3%+15.6%$106.57MN/A-3.3120Analyst ForecastShort Interest ↑News CoverageGap DownTELATELA Bio2.5543 of 5 stars$2.67flat$9.25+246.4%-61.8%$105.17M$58.45M-1.58120MGXMetagenomi1.7823 of 5 stars$2.77-6.7%$16.67+501.7%N/A$103.65M$44.76M0.00236MLSSMilestone Scientific0.3379 of 5 stars$1.33flat$1.25-6.0%+120.8%$103.59M$9.83M-19.0030Analyst Forecast Related Companies and Tools Related Companies THMO Alternatives KEQU Alternatives ZURA Alternatives ECOR Alternatives MIST Alternatives ACHV Alternatives CRDL Alternatives TELA Alternatives MGX Alternatives MLSS Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KOOL) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredElon’s ultimate power move?THE ELON SHOCK All of Elon Musk’s strange behavior may soon make sense… and impact the markets in a way no ...Altimetry | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cesca Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cesca Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
